Ricardo Cesar Saldaña Espinoza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ricardo Cesar Saldaña Espinoza has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Niels Hansen Wacher-Rodarte
Clinical Epidemiology Research Unit, Unidad Médica de Alta Especialidad, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico
2 shared publications - Rita Angelica Gomez-Diaz
Clinical Epidemiology Research Unit, Unidad Médica de Alta Especialidad, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico
2 shared publications Adriana Leticia Valdez González
Unidad De Investigación en Epidemiología Clínica UMAE HE CMN SXXI, Mexico City, Mexico
1 shared publication- Adriana Leticia Valdez González
Clinical Epidemiology Research Unit, Unidad Médica de Alta Especialidad, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico
1 shared publication Alejandro Irvin Soto Briseño
Unidad De Investigación en Epidemiología Clínica UMAE HE CMN SXXI, Mexico City, Mexico
1 shared publication- Luz Angélica Ramírez-García
Servicio de Endocrinología, Unidad Médica de Alta Especialidad, Hospital de Gineco-Obstetricia No. 4 “Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social (IMSS), Rio de la Magdalena 289, Mexico City 01090, Mexico
1 shared publication
Latest Publications
- Open Access
Association of Oxidative Stress Markers with Incident Hyperglycemia in Gestational Diabetes Mellitus in an Educational Intervention
Background/Objective: This study is aimed to assess the link between oxidative stress markers and incident hyperglycemia in women with gestational diabetes mellitus (GDM) during an educational intervention. Methods: The study used a prospective cohort. Pregnant women with GDM who were 18–40 years old (n = 201) participated in an 18-month postpartum educational intervention emphasizing healthy practices (nutrition, breastfeeding, physical activity, and psychosocial support). GDM women were tested with an oral glucose tolerance test (OGTT) after the third month postpartum, and were classified as follows: (1) incident hyperglycemia (IHypergly) (n = 86) if they had a fasting plasma glucose (FPG) of 100–125 mg/dL, and impaired glucose tolerance of 2 h (140–199 mg/dL), or type 2 diabetes (T2D) with an FPG ≥ 126 or ≥200 mg/dL (2 h); and (2) without incident hyperglycemia (n = 115) if they had an FPG < 100 mg/dL and <140 mg/dL 2 h post-OGTT. Participants were evaluated at the end of pregnancy and post-intervention. Clinical, biochemical, anthropometric, dietary, and oxidative stress markers data (malondialdehyde, reduced glutathione, antioxidant capacity, carbonylated proteins, and adiponectin) were recorded. Multivariate logistic regression analysis identified an association between oxidative stress markers and incident hyperglycemia in women with GDM. Results: A total of 6% progressed to T2D, and 36.8% to prediabetes. At baseline, Ihypergly women exhibited elevated oxidative stress markers and adiponectin, and lower antioxidant capacity. Post-intervention, they showed higher antioxidant capacity, GSH, and adiponectin, and lower MDA. Basal malondialdehyde, pregestational BMI, HbA1c, and sugary food consumption positively correlated with Ihypergly. A high intake of antioxidants inversely correlated with incident hyperglycemia. Conclusions: Higher concentrations of plasma markers of oxidative stress are associated with postpartum incident hyperglycemia in women with gestational diabetes.
Open AccessAssociation of Oxidative Stress Markers with Incident Hyperglycemia in Gestational Diabetes Mellitus in an Educational Intervention
Background/Objective: This study is aimed to assess the link between oxidative stress markers and incident hyperglycemia in women with gestational diabetes mellitus (GDM) during an educational intervention. Methods: The study used a prospective cohort. Pregnant women with GDM who were 18–40 years old (n = 201) participated in an 18-month postpartum educational intervention emphasizing healthy practices (nutrition, breastfeeding, physical activity, and psychosocial support). GDM women were tested with an oral glucose tolerance test (OGTT) after the third month postpartum, and were classified as follows: (1) incident hyperglycemia (IHypergly) (n = 86) if they had a fasting plasma glucose (FPG) of 100–125 mg/dL, and impaired glucose tolerance of 2 h (140–199 mg/dL), or type 2 diabetes (T2D) with an FPG ≥ 126 or ≥200 mg/dL (2 h); and (2) without incident hyperglycemia (n = 115) if they had an FPG < 100 mg/dL and <140 mg/dL 2 h post-OGTT. Participants were evaluated at the end of pregnancy and post-intervention. Clinical, biochemical, anthropometric, dietary, and oxidative stress markers data (malondialdehyde, reduced glutathione, antioxidant capacity, carbonylated proteins, and adiponectin) were recorded. Multivariate logistic regression analysis identified an association between oxidative stress markers and incident hyperglycemia in women with GDM. Results: A total of 6% progressed to T2D, and 36.8% to prediabetes. At baseline, Ihypergly women exhibited elevated oxidative stress markers and adiponectin, and lower antioxidant capacity. Post-intervention, they showed higher antioxidant capacity, GSH, and adiponectin, and lower MDA. Basal malondialdehyde, pregestational BMI, HbA1c, and sugary food consumption positively correlated with Ihypergly. A high intake of antioxidants inversely correlated with incident hyperglycemia. Conclusions: Higher concentrations of plasma markers of oxidative stress are associated with postpartum incident hyperglycemia in women with gestational diabetes.
- 16 March 2022
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (4) , 447-452
Validation of the COVID-19 Fear Scale modified for application during the perinatal period
The COVID-19 Fear Scale (FCV-19S) allows screening in general population; however, there is no specific instrument in our population for screening in the perinatal period that considers fear relate...
- 16 March 2022
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (4) , 447-452
Validation of the COVID-19 Fear Scale modified for application during the perinatal period
The COVID-19 Fear Scale (FCV-19S) allows screening in general population; however, there is no specific instrument in our population for screening in the perinatal period that considers fear relate...